Aminoverse enables clients to accelerate and de-risk enzyme innovation in the early value chain from target reaction to tailored enzyme.
Founded in 2020 by a team of entrepreneurs and scientists with > 50 years of experience, Aminoverse’s CRO services combine enzyme wet lab expertise with in silico design and its proprietary AI tech stack covering EnzyNAV AI (for identifying the right enzyme), EnzyMAP AI (for selecting the truly best mutations), and EnzyREC AI (to recombine the best mutations).